Therapeutic Monoclonal Antibodies and Clinical Laboratory Tests: When, Why, and What Is Expected?

Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.22307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

What Is the Best Biological Process for Nitrogen Removal: When and Why?

English

Exploring Openness in Data and Science: What Is “Open,” to Whom, When, and Why?

Proceedings of the Association for Information Science and Technology
Computer ScienceLibraryInformation Sciences
2015English

What Is Needed and Why

Aslib Proceedings
1954English

Fatty Acid-Based Membrane Lipidomics: Why, What and When

Journal of Glycomics & Lipidomics
2018English

What Is Apoptosis, and Why Is It Important?

BMJ
2001English

What, Why, Who, When, and How of Software Requirements

Handbook of Research on Emerging Advancements and Technologies in Software Engineering
English

Integrated Flow-Through Purification for Therapeutic Monoclonal Antibodies Processing

mAbs
AllergyImmunology
2018English

Monoclonal Antibodies — A Proven and Rapidly Expanding Therapeutic Modality for Human Diseases

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2010English

Monoclonal Antibodies: A Tool in Clinical Research

Indian Journal of Clinical Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy